Clinical Trial Update: Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy [Phase 4]

View source ↗

Summary

A Phase 4 placebo-controlled trial of baclofen for gastroesophageal reflux disease in children with cerebral palsy has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Gastroesophageal Reflux Disease

Drugs mentioned

• Baclofen (generic) (baclofen)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Cerebral Palsy, GERD | Phase 4 | Status: WITHDRAWN